AMAG Pharmaceuticals to Present at the Needham Healthcare Conference Needham Healthcare Conference 2013 Business Wire LEXINGTON, Mass. -- April 26, 2013 AMAG Pharmaceuticals, Inc.(NASDAQ: AMAG) today announced thatWilliam Heiden, AMAG’s chief executive officer, will present at the Needham Healthcare ConferenceonWednesday, May 1, 2013at12:50 p.m. Eastern time. The presentation will include a company overview and business update. A live webcast of the presentation will be accessible through the Investors section of the company’s website atwww.amagpharma.com. Following the conference, the webcast will be archived on theAMAG Pharmaceuticals, Inc.website untilJune 1, 2013. About AMAG AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company that manufactures and markets Feraheme® (ferumoxytol) Injection for Intravenous (IV) use in the United States. Along with driving organic growth of its lead product, AMAG intends to expand its portfolio with additional commercial-stage specialty pharmaceuticals. The company is seeking complementary products that leverage the company’s commercial footprint and focus on hematology and oncology centers and hospital infusion centers. For additional company information, please visit www.amagpharma.com. Contact: AMAG Pharmaceuticals, Inc. Amy Sullivan, 617-498-3303
AMAG Pharmaceuticals to Present at the Needham Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.